These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 16938802)

  • 1. Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.
    Ala-Korpela M; Sipola P; Kaski K
    Ann Med; 2006; 38(5):322-36. PubMed ID: 16938802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.
    Briley-Saebo KC; Mulder WJ; Mani V; Hyafil F; Amirbekian V; Aguinaldo JG; Fisher EA; Fayad ZA
    J Magn Reson Imaging; 2007 Sep; 26(3):460-79. PubMed ID: 17729343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
    Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM
    Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging by cardiovascular MR.
    Cyrus T; Lanza GM; Wickline SA
    J Cardiovasc Magn Reson; 2007; 9(6):827-43. PubMed ID: 18066742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.
    Calcagno C; Mani V; Ramachandran S; Fayad ZA
    Angiogenesis; 2010 Jun; 13(2):87-99. PubMed ID: 20526859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques.
    Wilensky RL; Song HK; Ferrari VA
    J Am Coll Cardiol; 2006 Apr; 47(8 Suppl):C48-56. PubMed ID: 16631510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular molecular imaging: an overview.
    Saraste A; Nekolla SG; Schwaiger M
    Cardiovasc Res; 2009 Sep; 83(4):643-52. PubMed ID: 19553359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance molecular imaging contrast agents and their application in atherosclerosis.
    Mulder WJ; Strijkers GJ; Vucic E; Cormode DP; Nicolay K; Fayad ZA
    Top Magn Reson Imaging; 2007 Oct; 18(5):409-17. PubMed ID: 18025995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging and spectroscopy methods for molecular imaging.
    Vande Velde G; Baekelandt V; Dresselaers T; Himmelreich U
    Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):565-85. PubMed ID: 20016450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular molecular MR imaging.
    Lamb HJ; van der Meer RW; de Roos A; Bax JJ
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1(Suppl 1):S99-104. PubMed ID: 17505824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.
    Botnar RM; Buecker A; Wiethoff AJ; Parsons EC; Katoh M; Katsimaglis G; Weisskoff RM; Lauffer RB; Graham PB; Gunther RW; Manning WJ; Spuentrup E
    Circulation; 2004 Sep; 110(11):1463-6. PubMed ID: 15238457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular magnetic resonance imaging with targeted contrast agents.
    Artemov D
    J Cell Biochem; 2003 Oct; 90(3):518-24. PubMed ID: 14523986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging.
    Fuster V; Fayad ZA; Moreno PR; Poon M; Corti R; Badimon JJ
    J Am Coll Cardiol; 2005 Oct; 46(7):1209-18. PubMed ID: 16198833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.
    Winter PM; Morawski AM; Caruthers SD; Fuhrhop RW; Zhang H; Williams TA; Allen JS; Lacy EK; Robertson JD; Lanza GM; Wickline SA
    Circulation; 2003 Nov; 108(18):2270-4. PubMed ID: 14557370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles.
    Lanza GM; Winter PM; Neubauer AM; Caruthers SD; Hockett FD; Wickline SA
    Curr Top Dev Biol; 2005; 70():57-76. PubMed ID: 16338337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of atherosclerosis: magnetic resonance imaging.
    Corti R; Fuster V
    Eur Heart J; 2011 Jul; 32(14):1709-19b. PubMed ID: 21508002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment.
    Saam T; Hatsukami TS; Takaya N; Chu B; Underhill H; Kerwin WS; Cai J; Ferguson MS; Yuan C
    Radiology; 2007 Jul; 244(1):64-77. PubMed ID: 17581895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnetic resonance imaging of atherosclerotic plaque].
    Ruehm SG
    Herz; 2003 Sep; 28(6):513-20. PubMed ID: 14564414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate magnetic resonance imaging of atherosclerotic plaques: change future strategies for the diagnosis and therapy of atherosclerotic disease.
    Liu XS; Xu JR
    Med Hypotheses; 2007; 68(3):656-60. PubMed ID: 17014968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3.0 T plaque imaging.
    Hinton-Yates DP; Cury RC; Wald LL; Wiggins GC; Keil B; Seethmaraju R; Gangadharamurthy D; Ogilvy CS; Dai G; Houser SL; Stone JR; Furie KL
    Top Magn Reson Imaging; 2007 Oct; 18(5):389-400. PubMed ID: 18025993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.